Clinical Trial Update: Safety & Tolerability of Cinacalcet in Pediatric Patients With Chronic Kidney Disease and Secondary Hyperparathyroidism [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and tolerability of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism; study termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hyperparathyroidism

Drugs mentioned

• cinacalcet (cinacalcet hydrochloride)

Snippet

Sponsor: Amgen | Conditions: Chronic Kidney Disease, Hyperparathyroidism, Secondary | Phase 2 | Status: TERMINATED | Results posted: 2017-08-11